Boardminder

    Reshma Kewalramani

    1 board
    Healthcare
    As of 8/31/2026

    0.35

    Boardminder Score™

    Top 42% of 4,262 directors

    Lower scoreHigher score

    6.7

    Avg Tenure (yrs)

    Shorter tenure than 50% of directors

    ShorterLonger

    $4.1M

    Total Compensation

    Lower than 1% of 3,007 one-seat directors

    LowerHigher
    Board Seats Breakdown
    Vertex Pharmaceuticals Incorporated
    VRTX
    F500 #363
    Chief Executive Officer and President
    Healthcare
    Seat Score
    0.35
    Tenure
    6.7 yrs
    Compensation
    $4.1M
    Excess Return
    +73.1%